Joe's a deal maker. It seems like a lot of productive activity...all of it resting on the 'great unknown', i.e., whether the peptides kick corona virus butt. And that we still don't know. (it did appear, however, that the continuing 'we don't know' was the result of GNBT not being able to pony up the money to pay the two labs which were doing the peptide analysis...so maybe they can now get that bill paid and we move forward.) So if it turns out that the peptides 'work', then we have something. If not, it all collapses. I'm steeling myself for either eventuality.